Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4Gynecologic 1

Conditions

Ovarian Neoplasms 32Testicular Neoplasms 13Carcinoma, Ovarian Epithelial 9Testicular Germ Cell Tumor 7Teratoma 7Ovarian Germ Cell Cancer 7Sarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Central Nervous System Neoplasms 4Osteosarcoma 3Neoplasms 3Lung Neoplasms 3Fallopian Tube Neoplasms 3Endodermal Sinus Tumor 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Seminoma 2Recurrence 2Optic Nerve Glioma 2Neuroblastoma 2Melanoma 2Medulloblastoma 2Gestational Trophoblastic Disease 2Drug-Related Side Effects and Adverse Reactions 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Carcinoma, Embryonal 2Brenner Tumor 2Breast Neoplasms 2

Interventions

Doxorubicin 5Ifosfamide 4Filgrastim 4belinostat 2Radiotherapy 2Carboplatin 2saracatinib 1perifosine 1brostallicin 1Vincristine 1Trabectedin 1Topotecan 1Thiotepa 1Temozolomide 1Sunitinib 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Microscopy, Electron 1Mass Spectrometry 1Injections 1Imatinib Mesylate 1Fluorouracil 1Etoposide 1Epirubicin 1Dactinomycin 1Cyproheptadine 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1CYT-6091 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosarcoma × Etoposide × Gynecologic × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡